en · de · es · fr · pt
peptide-index.peptides6155.com › Guide › Peptide Structure And Receptor Pharmacology — Research Overview

Peptide Structure And Receptor Pharmacology — Research Overview

By Editorial Desk · published 2025-09-09 · last reviewed 2025-09-30 · Guide

Everything below concerns chain of custody. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2025-09-30. Numbers and descriptions here follow the published literature rather than marketing material.

Peptide Structure and Receptor Pharmacology

The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.

Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.

Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.

Tirzepatide 分子背景与靶点

Tirzepatide 是一种由 39 个氨基酸组成的合成肽,分子结构上以 GIP 序列为骨架并引入脂肪酸侧链修饰,使其能够同时与葡萄糖依赖性促胰岛素多肽(GIP)受体和胰高血糖素样肽-1(GLP-1)受体结合。这种双重激动特性使它在同类肽类药物中区别于选择性 GLP-1 受体激动剂。该分子最早由一家制药公司在 2010 年代报道,随后进入糖尿病与体重管理领域的临床研究。

在生理层面,GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素,进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路,使胰岛素分泌的葡萄糖依赖性增强,并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比,双靶点作用在血糖控制和体重变化上的效应幅度更大,但具体贡献比例仍在研究之中。

脂肪酸侧链的存在使该肽与血浆白蛋白结合能力增强,从而延长循环半衰期,支持每周一次给药的用药间隔。白蛋白结合同时改变组织分布特征,减慢肾脏清除速度。该设计思路在多种长效肽类药物中被反复采用,属于既定的药代动力学策略。

Tirzepatide at a glance

PropertyValueNotes
Molar massapproximately 4813 Dacalculated from the 39-residue sequence
Appearancewhite to off-white powdertypical of lyophilised peptide material
Solubility classfreely soluble in watermeasured value depends on salt form and pH
Plasma protein binding>99 percentlinked to the fatty diacid side chain
Classdual GIP and GLP-1 receptor agonistreceptor activity varies with the assay used

Analytical Characterization and Storage

Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.

Analytical characterization of tirzepatide typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) for purity assessment and peptide mapping. Mass spectrometry, often coupled with electrospray ionization, confirms molecular weight and sequence integrity. Amino acid analysis and capillary electrophoresis may also be used to detect impurities or degradation products. These methods are essential for batch release and stability studies.

Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.

Related pages on this site

Handling, Storage, and Analytical Methods

Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.

Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.

Notes from published material

==== Nations ==== Bahrain: Bahrain called for a lasting solution that will prevent Iran from getting nuclear weapons or from doing things that could destabilize the region. France: President Emmanuel Macron said that he remained concerned about the "critical" situation in Lebanon, after Israel continued its strikes and occupation of southern Lebanon after the ceasefire, stating that this "cannot be a long-term solution." France also looked forward to securing shipping through the Strait of Hormuz. Germany: Germany urged Iran to respect the ceasefire and to allow ships to cross the Strait of Hormuz safely and freely. They also urged Iran to take advantage of the opportunity for negotiations. India: The Indian Ministry for External Affairs welcomed the US-Iran ceasefire agreement and called for an early end to the conflict for "unimpeded" trade flow through the Strait of Hormuz. Iraq: The Iraqi oil ministry said on 9 April that no Iraqi ships had crossed the Strait since the ceasefire came into effect. Kuwait: Kuwait's foreign ministry urged Iran and its "proxies, including factions, militias, and armed groups loyal to it" to cease all hostilities against Gulf Arab states. Qatar: Qatar's foreign ministry considered the ceasefire "an initial step toward de-escalation" and hoped Iran would "cease all hostile acts and practices that undermine regional stability." Russia: Russia welcomed the ceasefire and expressed hope that the United States would be able to resume peace negotiations in the Russo-Ukrainian war.

4.7 to 6.1 million (male), 4.2 to 5.4 million (female) erythrocytes: Red blood cells contain the blood's hemoglobin and distribute oxygen. Mature red blood cells lack a nucleus and organelles in mammals. The red blood cells (together with endothelial vessel cells and other cells) are also marked by glycoproteins that define the different blood types. The proportion of blood occupied by red blood cells is referred to as the hematocrit, and is normally about 45%. The combined surface area of all red blood cells of the human body would be roughly 2,000 times as great as the body's exterior surface. 4,000–11,000 leukocytes: White blood cells are part of the body's immune system; they destroy and remove old or aberrant cells and cellular debris, as well as attack infectious agents (pathogens) and foreign substances. The cancer of leukocytes is called leukemia. 200,000–500,000 thrombocytes: Also called platelets, they take part in blood clotting (coagulation). Fibrin from the coagulation cascade creates a mesh over the platelet plug.

While advertising of tobacco products is banned in most countries, television and radio e-cigarette advertising in several countries may be indirectly encouraging traditional cigarette use. E-cigarette advertisements are also in magazines, newspapers, online, and in retail stores. Between 2010 and 2014, e-cigarettes were second only to cigarettes as the top advertised product in magazines. As cigarette companies have acquired the largest e-cigarette brands, they currently benefit from a dual market of smokers and e-cigarette users while simultaneously presenting themselves as agents of harm reduction. This raises concerns about the appropriateness of endorsing a product that directly profits the tobacco industry. There is no evidence that the cigarette brands are selling e-cigarettes as part of a plan to phase out traditional cigarettes, despite some stating to want to cooperate in "harm reduction". E-cigarette advertising for using e-cigarettes as a quitting tool have been seen in the US, UK, and China, which have not been supported by regulatory bodies. In the US, six large e-cigarette businesses spent $59.3 million on promoting e-cigarettes in 2013. In the US and Canada, over $2 million is spent yearly on promoting e-cigarettes online. E-cigarette websites often made unscientific health statements in 2012. The ease to get past the age verification system at e-cigarette company websites allows underage individuals to access and be exposed to marketing.

=== Controlled-release formulations === Controlled or modified-release formulations are designed to deliver medications at a steady rate over time, helping maintain consistent drug levels in the bloodstream. This steady release reduced how often patients need to take their medication and minimizes the ups and downs in drug concentration that can cause side effects or lower effectiveness. These systems often take the form of matrix tablets, osmotic pumps, and reservoir-type devices, all of which use physical or chemical barriers to regulate how the drug is released. This approach is especially useful for chronic conditions such as high blood pressure, diabetes, or chronic pain, where maintaining stable therapeutic levels is key to keeping symptoms under control. The concept of controlled-release medication dates back to the 1950s, when Dexedrine became the first such formulation on the market. This era saw the introduction of transdermal patches, which deliver drugs slowly through the skin. As technology progressed, new formulations were developed to match the specific properties of different drugs. Examples include long-acting depot injections for medication like antipsychotics and hormone therapies, which remain effective for weeks or even months after a single dose. Since the late 1990s, research has increasingly turned to nanotechnology as a way to improve controlled-released drug delivery.

Sources: en.wikipedia.org

Background from the literature

=== Government, economic, and military institutions === The end of the Cold War also coincided with the end of apartheid in South Africa. Declining Cold War tensions in the later years of the 1980s meant that the apartheid regime was no longer supported by the West because of its anticommunism, but it was now condemned with an embargo. In 1990, Nelson Mandela was freed from prison and the regime began steps to end apartheid. This culminated in the first democratic elections in 1994, which resulted in Mandela being elected as President of South Africa. Socialist and communist parties around the world saw drops in membership after the Berlin Wall fell, and the public felt that free-market ideology had won. Libertarian, neoliberal, nationalist and Islamist parties, on the other hand, benefited from the fall of the Soviet Union. As capitalism had "won," as people saw it, socialism and communism in general declined in popularity. Social democrats in Scandinavia privatized many of their institutions in the 1990s, and a political debate on modern economics was reopened. Scandinavian nations are often now seen as social democrat (see Nordic model). It has been posited by some scholars that the end of communism as a global force in the post–Cold War era allowed neoliberal capitalism to become the dominant global system, which has resulted in rising economic inequality.

Beef jerky from Inner Mongolia is the most popular jerky product in all of China and is classified into traditional and modern beef jerky by air drying outdoors (hand-made) or thermal drying (large-scale industrial production), respectively.

=== R139w === One further single nucleotide polymorphism, found homozygous in 0% to 5% of different ethnic population, is leading to an amino acid exchange on position 139 from arginine to tryptophane. Furthermore, an alternative RNA splicing site is created leading to a loss of the quinone binding site. The variant protein of NQO1*3 has similar stability as its wild-type counterpart. The variation between the two is substrate specific and it has reduced activity for some substrates. It has been recently shown that the NQO1*3 polymorphism may also lead to reduced NQO1 protein expression.

The Life Sciences Institute (LSI) is a collaborative, multidisciplinary research institution located on the campus of the University of Michigan in Ann Arbor. It encompasses 27 faculty-led teams from 13 schools and departments throughout U-M. Of the university's $823 million in research expenditures, more than half is allocated for research in the life sciences, and the LSI is a cornerstone of this effort.

High-CRI LED lighting – LED lighting source Hiroshi Amano – Japanese materials scientist (born 1960) Isamu Akasaki – Japanese materials scientist (1929–2021) LED Strip Light – Flexible strip of surface mounted light-emitting diodes LED tattoo – Theoretical body modification List of light sources – Devices and processes that produce light MicroLED – Emerging flat-panel display technology Perovskite light-emitting diode – Postulated lighting technology Shuji Nakamura – Japanese–American electronics engineer (born 1954) Superluminescent diode – Optoelectronics component

Sources: en.wikipedia.org

Frequently asked questions

Is tirzepatide a small molecule or a peptide?

It is a synthetic peptide of 39 amino acids bearing a lipid side chain. Its size and architecture place it outside the small-molecule class, and laboratories generally handle it with the precautions used for biologic-like molecules.

Why is the dosing interval long?

The fatty diacid side chain promotes strong binding to serum albumin, which slows clearance and yields a half-life of roughly five days. That profile supports once-weekly administration in clinical use.

Does it act equally at both receptors?

In vitro assays detect activity at both the GIP and GLP-1 receptors, but the activity ratio depends on the assay system and the signalling pathway measured. The relative contribution of each receptor to clinical effects is still being characterised.

Tirzepatide 属于哪一类分子?

它属于合成修饰肽,同时激动 GIP 与 GLP-1 两种肠促胰素受体。这类分子通常被称为双重肠促胰素受体激动剂,与选择性 GLP-1 激动剂在靶点范围上不同。

Network